PHA Nanoparticles for Biocompatible Metal Nanostructure Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for non-invasive systems in the medical field, particularly in oncology, that can simultaneously perform diagnostic and therapeutic functions, with biocompatible carriers to deliver functional metal nanostructures effectively to diseased tissues without causing systemic adverse effects.
Innovation Solution
Biocompatible polymeric nanoparticles composed of polyhydroxyalkanoate (PHA) are used to encapsulate functional metal nanostructures such as gold nanorods and magnetic nanoparticles, ensuring stability and effective delivery to tissues while maintaining biofunctionality, with sizes below 200 nm for efficient systemic circulation and interaction with cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If functional metal nanostructures are delivered using conventional carriers, then diagnostic and therapeutic functions can be achieved, but systemic adverse effects occur and biocompatibility is compromised
Solution Approach 1:
The patent uses polyhydroxyalkanoate (PHA) biopolymer nanoparticles as an intermediary carrier to deliver functional metal nanostructures (gold nanorods, magnetic nanoparticles) to target tissues. The PHA carrier mediates between the functional nanostructures and the biological system, providing biocompatibility and preventing systemic adverse effects while maintaining the diagnostic and therapeutic functions of the embedded metal structures.
Solution Approach 2:
The invention creates composite nanoparticles consisting of a PHA biopolymer matrix containing functional metal nanostructures (gold nanorods, magnetite, maghemite). This composite structure combines the biocompatibility and biodegradability of PHA with the functional properties of metal nanoparticles, achieving both safety and efficacy in theranostic applications.
2Productivity
If nanoparticle size is reduced to enhance systemic circulation and cellular interaction, then delivery efficiency improves, but carrier stability and nanostructure functionality may be compromised
Solution Approach 1:
The patent optimizes the size parameter of PHA nanoparticles to the nanometric range (below 200 nm) to enhance systemic circulation and cellular uptake efficiency. This parameter change maintains carrier stability through the inherent properties of PHA biopolymer while improving delivery efficiency to target tissues and cells.
3Adaptability or versatility
If multiple functional metal nanostructures are incorporated to achieve simultaneous diagnostic and therapeutic functions, then theranostic capability improves, but system complexity increases
Solution Approach 1:
The PHA nanoparticle carrier is designed with universal multi-functionality to simultaneously accommodate different types of functional metal nanostructures (gold nanorods for photothermal therapy and imaging, magnetic nanoparticles for MRI and magnetic targeting). This single carrier system performs multiple functions including drug delivery, imaging, and therapy, reducing the need for separate systems.
Solution Approach 2:
The invention merges diagnostic and therapeutic functions into a single integrated nanoparticle system. PHA nanoparticles are combined with functional metal structures to create unified theranostic agents that can simultaneously perform imaging (via magnetic or optical properties) and therapy (via hyperthermia or drug delivery), simplifying the overall treatment approach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These nanoparticles act as effective contrast agents for diagnostic imaging and therapeutic agents for cancer treatment, providing precise diagnosis and targeted thermoablation of cancer cells, with no significant aggregation or systemic toxicity, enhancing the resolution and effectiveness of imaging and therapeutic interventions.
Implementation Method 1
GNRs have two distinct plasmon resonance bands: one due to the oscillations of the electrons on the transverse axis of the rod, which falls at around 520 nm, the other instead due to the oscillations of the electrons on the longitudinal axis, which, on the other hand, falls at higher wavelengths, around 700 nm
Implementation Method 2
The magnetic nanoparticles can be injected directly into the body to reach the tumoral mass and heated by means of an alternating magnetic field. This technique, called 'hyperthermia'
Implementation Method 3
heated by means of an alternating magnetic field
Implementation Method 4
functional metal nanostructures can be charged into nanoparticles of a polyhydroxyalkanoate (PHA), which has a high biocompatibility and acts as an effective carrier for functional metal nanostructures
Data Source
AI summary
Biocompatible polymeric nanoparticles may include: a biocompatible polymer and/or functional metal nanostructures. The biocompatible polymer may be a polyhydroxyalkanoate (PHA). The functional metal nanostructures may include at least one noble metal, at least one magnetic metal oxide, or mixtures thereof. The biocompatible polymeric nanoparticles may have an average size less than or equal to 200 nanometers (nm).